TRPV4 and breast carcinoma: In contrast, TRPV4 silencing reduced the above effect, which was not observed in breast cancer cell lines exhibiting low or negligible levels of TRPV4 expression (Peters et al., 2017), thereby suggesting that the mechanism underlying GSK1016790A-induced cell death is mediated through TRPV4.